左心室肥厚诊断和治疗临床路径中国专家共识2023  

Clinical Pathway of Diagnosis and Treatment of Left Ventricular Hypertrophy:Chinese Expert Consensus 2023

作　　者：中国医师协会心血管内科医师分会心力衰竭学组 心衰中心心肌病专家委员会 董吁钢[2] 杨杰孚[3] Heart Failure Core Group of the Cardiovascular Physicians Branch of the Chinese Medical Doctor Association;Expert Committee of the Chinese Heart Failure Center on Cardiomyopathy

机构地区：[1]不详 [2]中山大学附属第一医院 [3]北京医院

出　　处：《中国循环杂志》2024年第1期17-28,共12页Chinese Circulation Journal

摘　　要：左心室肥厚是一类常见的心脏结构性改变,经影像学检查确诊。起病隐匿,早期症状不典型,易被忽视,延误诊治。多种疾病和情形可致左心室肥厚,近年来针对部分特定病因的治疗显示可显著改善患者预后,故需重视对左心室肥厚相关疾病的病因诊断。本专家共识由中国医师协会心血管内科医师分会心力衰竭学组和心衰中心心肌病专家委员会组织编写,全面介绍了左心室肥厚的早期筛查线索、规范诊治及随访路径。旨在深化广大临床一线医务工作者(尤其是基层医院)加强对左心室肥厚的认识,建立早期识别、早期转诊的意识,提高对常见及罕见左心室肥厚相关疾病的诊治能力,减少漏诊和误诊。Left ventricular hypertrophy(LVH)is a common form of cardiac structure change,which could be identified via cardiac imaging mordalities.The diagnosis and treatment of LVH is inclined to delay by insidious onset and atypical features in early phase.Many risk factors can lead to LVH.More recently,some etiologyspecific treatments show significant important in terms of therapy efficacy and significantly improve the prognosis in pateinst with LVH.Thus,it is of importance to pay attention to etiological diagnosis of LVH.Experts from the Heart Failure Core Group of the Cardiovascular Physicians Branch of the Chinese Medical Doctor Association and the Expert Committee of the Chinese Heart Failure Center on Cardiomyopathy jointly developed this consensus to summarize the early screening,diagnosis and treatment regimens,and follow-up pathway of LVH.This consensus is aimed to strengthen the understanding of LVH in frontline healthcare workers,especially the community physicians,to reduce the risk of misdiagnosis or missed diagnosis of LVH.

关 键 词：左心室肥厚 早期筛查 诊断路径 治疗路径 病因诊断 肥厚型心肌病 心脏淀粉样变 法布雷病 

分 类 号：R54[医药卫生—心血管疾病]